Medicines regulator approves vaginal ring for HIV prevention
14 March 2022 - 19:15
SA’s medicines regulator has approved a vaginal ring that slowly releases the drug dapirivine, offering women protection from HIV for up to a month at a time.
The development has been hailed by HIV advocates as a milestone in the quest to provide women with more options for reducing their risk of contracting the virus, but it is not clear when it will be available in SA...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.